NCLifeSci Medical Device Luncheon and Forum 2024: Diagnostic Testing - Will FDA’s Final Rule be the Final Word
Name:
NCLifeSci Medical Device Luncheon and Forum 2024: Diagnostic Testing - Will FDA’s Final Rule be the Final Word
Date:
May 21, 2024
Time:
11:30 AM - 2:00 PM EDT
Registration:
Sorry, member registration for this event is closed.
Event Description:
Join NCLifeSci members for a networking lunch and a panel discussion focused on diagnostic testing. Hear from key leaders on the importance of getting the diagnostics market right, as it’s a critical part in the continuum of care. Therapeutic and device companies are finding and creating cures and solutions that should be based on accurate diagnoses.
Panelists will
Thank you to the Economic Development Partnership of North Carolina and Maynard Nexsen for sponsoring this forum.
If you are interested in sponsoring the Medical Device Forum, contact Membership Director Natacha Janvier for more details.
Panelists will
- cover the oversight and quality of laboratory-derived tests and in vitro diagnostics,
- discuss current regulation and modernization of regulation,
- discuss pros and cons of FDA rule making versus legislation and FDA oversight, and
- explore how to advance patient care and public health.
- Anna Abram, senior advisor, Akin Gump Strauss Hauer & Feld LLP
- Nicole Bell, chief business officer, Galaxy Diagnostics
- Matthew Roberts, health care practice group leader and regulatory section head, Maynard Nexsen (moderator)
- Hannah Yan, senior research scientist, regulatory strategy and product development, RTI International
Thank you to the Economic Development Partnership of North Carolina and Maynard Nexsen for sponsoring this forum.
If you are interested in sponsoring the Medical Device Forum, contact Membership Director Natacha Janvier for more details.
